Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

Click for more information

0.00%

1.4¢ chimeric therapeutics limited

Charting Only, page-181

First 181 Last

Share
Profile

Follow
JabraD

15,516 Posts.

1283

10/05/23

11:57

Post #: 67697934
Share

Originally posted by JabraD: ↑

Although this looks like a good area to buy IMO it is not worth the gamble until funds secured.

Think of it like this, they need to raise around 10-20 mill IMO, considering the share price is low theyll have to do it at a discount. Imagine say 10 million at 4 cents, thats 250 million shares. they would be nearing close to 1 bill shares on issue if they were to raise 20 million, then they would have to churn through all those shares.

Bio space is hard atm and raising cash even harder. Hence why I look for cashed up bios with a pathway to results.

Unfortunately CHM has timed this terribly and are left with no choice now with backs against the wall.

Charts broken down so there is no real defined bottom yet. Plenty of time to base and take a position ONCE FUNDS ARE RAISED. Till then this is a monster gamble with a possible huge dilution on the cards, hence the rampant selling IMO

Expand

This price action IMO looks like someone knows a raise is coming and is not happy with the price/dilution. Who knows, but decent sell down happening now

CHM Price at posting: 4.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 272 more messages in this thread...

First 181 Last

Add CHM (ASX) to my watchlist